Paktiya Teja‐Isavadharm

2.2k total citations
36 papers, 1.3k citations indexed

About

Paktiya Teja‐Isavadharm is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Paktiya Teja‐Isavadharm has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Public Health, Environmental and Occupational Health, 15 papers in Computational Theory and Mathematics and 15 papers in Pharmacology. Recurrent topics in Paktiya Teja‐Isavadharm's work include Malaria Research and Control (32 papers), Computational Drug Discovery Methods (15 papers) and Drug-Induced Hepatotoxicity and Protection (13 papers). Paktiya Teja‐Isavadharm is often cited by papers focused on Malaria Research and Control (32 papers), Computational Drug Discovery Methods (15 papers) and Drug-Induced Hepatotoxicity and Protection (13 papers). Paktiya Teja‐Isavadharm collaborates with scholars based in Thailand, United States and United Kingdom. Paktiya Teja‐Isavadharm's co-authors include Nicholas J. White, Dennis E. Kyle, Sasithon Pukrittayakamee, Paul N. Newton, Yupin Suputtamongkol, H. Kyle Webster, Krisada Jongsakul, George Watt, Thomas G. Brewer and Mark M. Fukuda and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Paktiya Teja‐Isavadharm

36 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paktiya Teja‐Isavadharm 958 348 326 290 204 36 1.3k
J. Kevin Baird 1.5k 1.6× 344 1.0× 267 0.8× 295 1.0× 178 0.9× 35 1.8k
S Vanijanonta 1.2k 1.3× 345 1.0× 302 0.9× 248 0.9× 124 0.6× 47 1.5k
L Phaipun 1.8k 1.9× 434 1.2× 476 1.5× 293 1.0× 223 1.1× 14 2.0k
P.A. Winstanley 994 1.0× 260 0.7× 170 0.5× 168 0.6× 191 0.9× 33 1.4k
I. S. Adagu 925 1.0× 213 0.6× 208 0.6× 190 0.7× 254 1.2× 28 1.3k
A Brockman 1.7k 1.8× 429 1.2× 450 1.4× 253 0.9× 200 1.0× 18 1.8k
Walter R. J. Taylor 1.0k 1.1× 258 0.7× 293 0.9× 154 0.5× 122 0.6× 24 1.3k
E.K. Mberu 1.4k 1.4× 390 1.1× 263 0.8× 184 0.6× 355 1.7× 36 1.8k
W.H. Wernsdorfer 1.2k 1.2× 294 0.8× 245 0.8× 148 0.5× 118 0.6× 49 1.4k
W. H. Wernsdorfer 1.2k 1.3× 229 0.7× 184 0.6× 209 0.7× 145 0.7× 70 1.5k

Countries citing papers authored by Paktiya Teja‐Isavadharm

Since Specialization
Citations

This map shows the geographic impact of Paktiya Teja‐Isavadharm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paktiya Teja‐Isavadharm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paktiya Teja‐Isavadharm more than expected).

Fields of papers citing papers by Paktiya Teja‐Isavadharm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paktiya Teja‐Isavadharm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paktiya Teja‐Isavadharm. The network helps show where Paktiya Teja‐Isavadharm may publish in the future.

Co-authorship network of co-authors of Paktiya Teja‐Isavadharm

This figure shows the co-authorship network connecting the top 25 collaborators of Paktiya Teja‐Isavadharm. A scholar is included among the top collaborators of Paktiya Teja‐Isavadharm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paktiya Teja‐Isavadharm. Paktiya Teja‐Isavadharm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teja‐Isavadharm, Paktiya, Montip Gettayacamin, Jonathan Berman, et al.. (2014). Anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model. Malaria Journal. 13(1). 409–409. 2 indexed citations
2.
Li, Qigui, Shon Remich, Scott R. Miller, et al.. (2014). Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study. Malaria Journal. 13(1). 281–281. 11 indexed citations
3.
Rutvisuttinunt, Wiriya, Suwanna Chaorattanakawee, Stuart D. Tyner, et al.. (2012). Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates. Malaria Journal. 11(1). 325–325. 7 indexed citations
4.
Starzengrüber, Peter, Paul Swoboda, Hans‐Peter Fuehrer, et al.. (2012). Current Status of Artemisinin-Resistant falciparum Malaria in South Asia: A Randomized Controlled Artesunate Monotherapy Trial in Bangladesh. PLoS ONE. 7(12). e52236–e52236. 20 indexed citations
5.
Bethell, Delia, Youry Se, Chanthap Lon, et al.. (2011). Artesunate Dose Escalation for the Treatment of Uncomplicated Malaria in a Region of Reported Artemisinin Resistance: A Randomized Clinical Trial. PLoS ONE. 6(5). e19283–e19283. 52 indexed citations
6.
Bethell, Delia, Youry Se, Chanthap Lon, et al.. (2010). Dose‐Dependent Risk of Neutropenia after 7‐Day Courses of Artesunate Monotherapy in Cambodian Patients with Acute Plasmodium falciparum Malaria. Clinical Infectious Diseases. 51(12). e105–e114. 38 indexed citations
7.
Noedl, Harald, Youry Se, Sabaithip Sriwichai, et al.. (2010). Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia. Clinical Infectious Diseases. 51(11). e82–e89. 146 indexed citations
8.
Teja‐Isavadharm, Paktiya, Gavin D. Watt, Chirapa Eamsila, et al.. (2001). Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria.. American Journal of Tropical Medicine and Hygiene. 65(6). 717–721. 65 indexed citations
9.
Suputtamongkol, Yupin, Paul N. Newton, Brian Angus, et al.. (2001). A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria. British Journal of Clinical Pharmacology. 52(6). 655–661. 35 indexed citations
10.
Newton, Paul N., et al.. (1999). Pharmacokinetics of quinine and 3-hydroxyquinine in severe falciparum malaria with acute renal failure. Transactions of the Royal Society of Tropical Medicine and Hygiene. 93(1). 69–72. 18 indexed citations
11.
Sabchareon, Arunee, P. Attanath, Pornthep Chanthavanich, et al.. (1998). Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.. American Journal of Tropical Medicine and Hygiene. 58(1). 11–16. 33 indexed citations
12.
Pukrittayakamee, S., S Looareesuwan, Timothy M. E. Davis, et al.. (1997). A study of the factors affecting the metabolic clearance of quinine in malaria. European Journal of Clinical Pharmacology. 52(6). 487–493. 57 indexed citations
13.
Bethell, Delia B., Paktiya Teja‐Isavadharm, Cao Xuan Thanh Phuong, et al.. (1997). Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 91(2). 195–198. 51 indexed citations
14.
Supanaranond, Wichai, Yupin Suputtamongkol, Timothy M. E. Davis, et al.. (1997). Lack of a significant adverse cardiovascular effect of combined quinine and mefloquine therapy for uncomplicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 91(6). 694–696. 22 indexed citations
15.
Watt, George, Charoen Chouriyagune, Pochaman Watcharapichat, et al.. (1996). Scrub typhus infections poorly responsive to antibiotics in northern Thailand. The Lancet. 348(9020). 86–89. 206 indexed citations
16.
Teja‐Isavadharm, Paktiya, François Nosten, Dennis E. Kyle, et al.. (1996). Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay. British Journal of Clinical Pharmacology. 42(5). 599–604. 79 indexed citations
17.
Ohrt, Colin, et al.. (1995). Pharmacokinetics of an extended-dose halofantrine regimen in patients with malaria and in healthy volunteers*. Clinical Pharmacology & Therapeutics. 57(5). 525–532. 13 indexed citations
18.
Brown, Arthur E., Paktiya Teja‐Isavadharm, & H. Kyle Webster. (1991). Macrophage activation in vivax malaria: fever is associated with increased levels of neopterin and interferon‐gamma. Parasite Immunology. 13(6). 673–679. 21 indexed citations
19.
Teja‐Isavadharm, Paktiya, et al.. (1991). Measurement of Ciprofloxacin in Human Plasma, Whole Blood, and Erythrocytes by High-Performance Liquid Chromatography. Therapeutic Drug Monitoring. 13(3). 263–267. 20 indexed citations
20.
Teja‐Isavadharm, Paktiya, et al.. (1991). An Improved High-Performance Liquid Chromatographic Method for the Simultaneous Measurement of Halofantrine and Desbutylhalofantrne in Human Serum. Therapeutic Drug Monitoring. 13(1). 64–68. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026